Tenax Therapeutics, Inc. · NASDAQ:TENX

Vestal Point Capital, LP reported a 9.90% stake in Tenax Therapeutics, Inc. (Schedule 13G)

Event Sep 30, 2024 · Filed Nov 14, 2025

Vestal Point Capital, LP reported a 9.90% stake in Tenax Therapeutics, Inc., 2,470,096 shares, as a passive investor on Sep 30, 2024. Filed Nov 14, 2025 (Schedule 13G).

Stake
9.90%
Shares
2,470,096
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Vestal Point Capital, LP9.90%2,470,096
Ryan Wilder9.90%2,470,096

Source

View original at SEC

Related